Literature DB >> 27079878

Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.

Niyati U Mehta1, Victor Grijalva1, Susan Hama1, Alan Wagner1, Mohamad Navab1, Alan M Fogelman1, Srinivasa T Reddy2.   

Abstract

OBJECTIVE: We previously reported that hemopexin (Hx), a heme scavenger, is significantly increased and associated with proinflammatory high-density lipoprotein under atherogenic conditions. Although it is established that Hx together with macrophages plays a role in mitigating oxidative damage, the role of Hx in the development of atherosclerosis is unknown. APPROACH AND
RESULTS: We used Hx and apoE double-knockout mice (HxE(-/-)) to determine the role of Hx in the development of atherosclerosis. HxE(-/-) mice had significantly more free heme, reactive oxygen species, and proinflammatory high-density lipoprotein in their circulation, when compared with control apoE(-/-) mice. Atherosclerotic plaque area (apoE(-/-)=9.72±2.5×10(4) μm(2) and HxE(-/-)=27.23±3.6×10(4) μm(2)) and macrophage infiltration (apoE(-/-)=38.8±5.8×10(3) μm(2) and HxE(-/-)=103.4±17.8×10(3) μm(2)) in the aortic sinus were significantly higher in the HxE(-/-) mice. Atherosclerotic lesions in the aortas were significantly higher in the HxE(-/-) mice compared with apoE(-/-) mice. Analysis of polarization revealed that macrophages from HxE(-/-) mice were more M1-like. Ex vivo studies demonstrated that HxE(-/-) macrophage cholesterol efflux capacity was significantly reduced when compared with apoE(-/-) mice. Injection of human Hx into HxE(-/-) mice reduced circulating heme levels and human Hx pretreatment of naive bone marrow cells ex vivo resulted in a shift from M1- to M2-like macrophages.
CONCLUSIONS: We conclude that Hx plays a novel protective role in alleviating heme-induced oxidative stress, improving inflammatory properties of high-density lipoprotein, macrophage phenotype and function, and inhibiting the development of atherosclerosis in apoE(-/-) mice.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cholesterol; heme; inflammation; macrophages; monocytes

Mesh:

Substances:

Year:  2016        PMID: 27079878      PMCID: PMC4882257          DOI: 10.1161/ATVBAHA.115.306991

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  58 in total

Review 1.  Other functions, other genes: alternative activation of antigen-presenting cells.

Authors:  S Goerdt; C E Orfanos
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

2.  Knockout-transgenic mouse model of sickle cell disease.

Authors:  T M Ryan; D J Ciavatta; T M Townes
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.

Authors:  U Chakravarthy; R G Hayes; A W Stitt; E McAuley; D B Archer
Journal:  Diabetes       Date:  1998-06       Impact factor: 9.461

4.  Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains.

Authors:  M Paoli; B F Anderson; H M Baker; W T Morgan; A Smith; E N Baker
Journal:  Nat Struct Biol       Date:  1999-10

5.  Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells.

Authors:  P Delafontaine; L Ku
Journal:  Cardiovasc Res       Date:  1997-01       Impact factor: 10.787

6.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.

Authors:  Rabea Asleh; Rachael Miller-Lotan; Michael Aviram; Tony Hayek; Michael Yulish; Joanne E Levy; Benjamin Miller; Shany Blum; Uzi Milman; Chen Shapira; Andrew P Levy
Journal:  Circ Res       Date:  2006-11-02       Impact factor: 17.367

8.  The influence of heme-binding proteins in heme-catalyzed oxidations.

Authors:  S H Vincent; R W Grady; N Shaklai; J M Snider; U Muller-Eberhard
Journal:  Arch Biochem Biophys       Date:  1988-09       Impact factor: 4.013

Review 9.  Redox regulation of stem/progenitor cells and bone marrow niche.

Authors:  Norifumi Urao; Masuko Ushio-Fukai
Journal:  Free Radic Biol Med       Date:  2012-10-17       Impact factor: 7.376

10.  Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

Authors:  Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461

View more
  15 in total

Review 1.  High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.

Authors:  Yi He; Vishal Kothari; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

2.  Physiologic and genetic evidence links hemopexin to triglycerides in mice and humans.

Authors:  H A Lawson; M Zayed; J P Wayhart; E Fabbrini; L Love-Gregory; S Klein; C F Semenkovich
Journal:  Int J Obes (Lond)       Date:  2017-01-25       Impact factor: 5.095

3.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

4.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

5.  Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma.

Authors:  Natasha A Winter; Peter G Gibson; Michael Fricker; Jodie L Simpson; Peter A Wark; Vanessa M McDonald
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

6.  Stroke sensitivity in the aged: sex chromosome complement vs. gonadal hormones.

Authors:  Louise D McCullough; Mehwish A Mirza; Yan Xu; Kathryn Bentivegna; Eleanor B Steffens; Rodney Ritzel; Fudong Liu
Journal:  Aging (Albany NY)       Date:  2016-07       Impact factor: 5.682

Review 7.  M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment.

Authors:  Ying Bi; Jixiang Chen; Feng Hu; Jing Liu; Man Li; Lei Zhao
Journal:  Neural Plast       Date:  2019-02-21       Impact factor: 3.599

Review 8.  Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease.

Authors:  Denise Burtenshaw; Michael Kitching; Eileen M Redmond; Ian L Megson; Paul A Cahill
Journal:  Front Cardiovasc Med       Date:  2019-08-02

Review 9.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

10.  Plasma Hemopexin ameliorates murine spinal cord injury by switching microglia from the M1 state to the M2 state.

Authors:  Dunxin Han; Zhongwang Yu; Weili Liu; Dou Yin; Yingyan Pu; Jifeng Feng; Yimin Yuan; Aijun Huang; Li Cao; Cheng He
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.